Overview

BEFORE Study, Efficacy of Refigura

Status:
Completed

Trial end date:
2018-04-16

Target enrollment:

Participant gender:

Summary

The BEFORE study ((B) EFficacy Of REfigura) is designed to demonstrate the efficacy of REFIGURA®. It is a double-blind, randomized, monocentric study.

Phase:

Phase 4

Details

Lead Sponsor:

Heilpflanzenwohl AG

Treatments:

(1-6)-alpha-glucomannan
Pharmaceutical Solutions